Effect of Co Q10 supplementation on Anti Mullerian hormone levels in ?patients with Polycystic ovary syndrome?

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017010320258N24

Enrollment

Registered

2017-01-12

Start date

2016-10-24

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic ovary syndrome?. Polycystic ovarian syndrome

Interventions

We prescribe 100 milligram tablet of Q10 ( Mix natural) in 3 months( 90 ?days) for all patients.?.

Treatment - Drugs

We prescribe 100 milligram tablet of Q10 ( Mix natural) in 3 months( 90 ?days) for all patients.?

Eligibility

Sex/Gender

Female

Age

15 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 15 to 45 years; Polycystic ovarian syndrome Exclusion criteria: side effect of drug; consumption supplement Co Q10 in 3 months

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Level of AMH. Timepoint: before prescribe and end of third months and end of drug. Method of measurement: ELISA.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Alireza Kamali

Arak University of Medical Sciences

alikamaliir@yahoo.com+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026